James M. McFarland

机构：Broad Institute · ORCID：0000-0001-9978-480X

发表论文 230 篇 · 总被引 14329 次 · h-index 36

代表论文

Genome-scale functional genomics identify genes preferentially essential for multiple myeloma cells compared to other neoplasias (2023 · Nature Cancer · 被引 43)
Partial gene suppression improves identification of cancer vulnerabilities when CRISPR-Cas9 knockout is pan-lethal (2023 · Genome biology · 被引 33)
BRD-810 is a highly selective MCL1 inhibitor with optimized in vivo clearance and robust efficacy in solid and hematological tumor models (2024 · Nature Cancer · 被引 29)
Germline variation contributes to false negatives in CRISPR-based experiments with varying burden across ancestries (2024 · Nature Communications · 被引 13)
Spontaneous persistent activity and inactivity in vivo reveals differential cortico-entorhinal functional connectivity (2024 · Nature Communications · 被引 3)
Abstract 506: ANJ810 is a highly selective novel MCL1 inhibitor with optimized in vivo clearance showing robust efficacy in preclinical solid and hematological tumor models (2023 · Cancer Research · 被引 1)